Cancer Immunotherapy

Cancer immunotherapy is a groundbreaking approach that uses the body’s immune system to fight cancer. This method has transformed cancer treatment, especially for advanced cancers like melanoma, lung cancer, and leukemia. Immunotherapy drugs, such as Pembrolizumab and Nivolumab, work by blocking proteins like PD-1 and CTLA-4 that help cancer cells evade immune detection. By inhibiting these checkpoints, immune cells can identify and attack cancer cells more effectively. CAR-T cell therapy, another form of immunotherapy, involves genetically modifying a patient’s T-cells to target cancer cells directly, showing remarkable results in blood cancers. Immunotherapy not only enhances the immune system’s response to cancer but can also lead to long-lasting remission. Current research aims to expand its application across different cancer types, improve patient response rates, and reduce side effects. As it continues to evolve, immunotherapy holds promise for more effective, targeted, and sustainable cancer treatment options.